Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANVS Annovis Bio, Inc.

盘后交易 05-01 19:16:10 EDT

6.11

+0.54

+9.69%

盘后6.16

+0.05+0.82%

19:10 EDT

最高6.31	最低5.46	成交量107.73万
今开5.46	昨收5.57	日振幅15.26%
总市值6,728万	流通市值4,975万	总股本1,101万
成交额641.78万	换手率13.23%	流通股本814.29万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANVS","market":"US","secType":"STK","nameCN":"Annovis Bio, Inc.","latestPrice":6.11,"timestamp":1714593600000,"preClose":5.57,"halted":0,"volume":1077337,"hourTrading":{"tag":"盘后","latestPrice":6.16,"preClose":6.11,"latestTime":"19:10 EDT","volume":36103,"amount":220701.57422699998,"timestamp":1714605015561},"delay":0,"floatShares":8142919,"shares":11011299,"eps":-6.228909,"marketStatus":"盘后交易","marketStatusCode":4,"change":0.54,"latestTime":"05-01 19:16:10 EDT","open":5.46,"high":6.31,"low":5.46,"amount":6417811.784058999,"amplitude":0.152603,"askPrice":6.74,"askSize":100,"bidPrice":6.08,"bidSize":64,"shortable":0,"etf":0,"ttmEps":-6.228909,"exchange":"NYSE","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1714608000000},"adr":0,"listingDate":1580274000000,"adjPreClose":5.57,"preHourTrading":{"tag":"盘前","latestPrice":5.498,"preClose":5.57,"latestTime":"09:29 EDT","volume":18872,"amount":104759.962888,"timestamp":1714570193609},"postHourTrading":{"tag":"盘后","latestPrice":6.16,"preClose":6.11,"latestTime":"19:10 EDT","volume":36103,"amount":220701.57422699998,"timestamp":1714605015561},"volumeRatio":0.394577},"requestUrl":"/m/hq/s/ANVS","defaultTab":"news","newsList":[{"id":"2432709005","title":"Annovis Bio, Inc.盘中异动 快速拉升5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432709005","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432709005?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:38","pubTimestamp":1714570714,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时38分，Annovis Bio, Inc.股票出现波动，股价大幅上涨5.03%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。该信息摘要如下：HC Wainwright & Co.：重申Annovis Bio评级，由买入调整至买入评级, 目标价30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050121383587e852ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050121383587e852ba&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431232303","title":"Annovis Bio, Inc.盘中异动 急速下跌9.96%报6.56美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431232303","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431232303?lang=zh_cn&edition=full","pubTime":"2024-04-30 21:32","pubTimestamp":1714483955,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日21时32分，Annovis Bio, Inc.股票出现异动，股价急速下挫9.96%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.09%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。该信息摘要如下：HC Wainwright & Co.：重申Annovis Bio评级，由买入调整至买入评级, 目标价30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021323587c3f684&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043021323587c3f684&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431197933","title":"HC Wainwright & Co.：重申Annovis Bio(ANVS.US)评级，由买入调整至买入评级, 目标价30.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2431197933","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431197933?lang=zh_cn&edition=full","pubTime":"2024-04-30 18:35","pubTimestamp":1714473333,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Annovis Bio(ANVS.US)评级，由买入调整至买入评级, 目标价30.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043018354087c371f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024043018354087c371f3&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431846223","title":"Acurx Pharmaceuticals, Inc.盘中异动 下午盘快速上涨5.31%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431846223","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431846223?lang=zh_cn&edition=full","pubTime":"2024-04-30 03:08","pubTimestamp":1714417686,"startTime":"0","endTime":"0","summary":"北京时间2024年04月30日03时08分，Acurx Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.31%。Acurx Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Acurx Pharmaceuticals, Inc.公司简介：Acurx Pharmaceuticals Inc是一家处于临床阶段的生物制药公司，正在开发一种新型抗生素，用于治疗由世界卫生组织、疾病控制和预防中心以及食品药品监督管理局列为优先病原体的细菌所引起的感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300308077a5758ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404300308077a5758ad&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431485528","title":"BUZZ-安诺维斯生物公司因阿尔茨海默氏症治疗的中期数据而暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2431485528","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431485528?lang=zh_cn&edition=full","pubTime":"2024-04-30 02:29","pubTimestamp":1714415380,"startTime":"0","endTime":"0","summary":"    4月29日 - ** 药物开发商Annovis Bio   股价跌幅高达71%，跌至逾三年低点5.23美元，最新跌幅为52.5%。** ANVS 的股票因波动多次停牌 ** 该公司的阿尔茨海默氏症实验性疗法未能通过    在达到中期试验目标方面显示出统计学意义。** 公司预计在未来两三个月内与美国 FDA 讨论这些数据，然后开展后期研究** 包括盘中走势在内，该股今年累计下跌约 60","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431681080","title":"更新版 2-更正-阿尔茨海默氏症治疗在中期研究中失利，安诺维公司股价暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2431681080","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431681080?lang=zh_cn&edition=full","pubTime":"2024-04-30 02:19","pubTimestamp":1714414776,"startTime":"0","endTime":"0","summary":"该公司表示，它相信这种药物可以 \"为患者带来症状和疾病调节方面的益处\"，并计划对早期阿尔茨海默病患者进行为期 18 个月的后期试验。在周一的交易中，Annovis公司的股票多次因波动而停牌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431111894","title":"Crinetics Pharmaceuticals, Inc.盘中异动 临近午盘大幅拉升5.02%报44.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431111894","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431111894?lang=zh_cn&edition=full","pubTime":"2024-04-29 23:59","pubTimestamp":1714406374,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日23时59分，Crinetics Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.02%。Crinetics Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.72%。Crinetics Pharmaceuticals, Inc.公司简介：Crinetics Pharmaceuticals Inc 是一家临床阶段的制药公司，专注于罕见内分泌疾病和内分泌相关肿瘤的新疗法的发现、开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429235934861ea22f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240429235934861ea22f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431898579","title":"更新版 1-安诺维斯的阿尔茨海默氏症治疗方法有助于改善试验中的认知能力","url":"https://stock-news.laohu8.com/highlight/detail?id=2431898579","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431898579?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:51","pubTimestamp":1714402303,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 )) (在第 2 和第 3 段中增加了更多细节)    路透4月29日 -    Annovis Bio   周一称，在一项中期试验中，其阿尔茨海默氏症治疗药物对患者认知能力的改善幅度明显增大。该公司的药物buntanetap通过减少大脑中淀粉样β蛋白的产生发挥作用，而淀粉样β蛋白被认为是阿尔茨海默氏症的标志。     Annovis公司计划根据这项试验的结果开展后期试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431864163","title":"Annovis Bio 公司报告阿尔茨海默氏症中期治疗试验取得积极成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2431864163","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2431864163?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:20","pubTimestamp":1714400443,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    路透4月29日 -    Annovis Bio   公司周一表示，其阿尔茨海默氏症治疗药物在一项中期试验中显示，阿尔茨海默氏症患者的认知能力明显提高。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2431863054","title":"Annovis Bio, Inc.盘中异动 早盘大幅下跌5.44%报17.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431863054","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431863054?lang=zh_cn&edition=full","pubTime":"2024-04-29 21:37","pubTimestamp":1714397870,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日21时37分，Annovis Bio, Inc.股票出现异动，股价大幅跳水5.44%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921375087e84bdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042921375087e84bdc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430209277","title":"Annovis Bio, Inc.盘中异动 急速拉升5.51%报14.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2430209277","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430209277?lang=zh_cn&edition=full","pubTime":"2024-04-26 21:32","pubTimestamp":1714138366,"startTime":"0","endTime":"0","summary":"北京时间2024年04月26日21时32分，Annovis Bio, Inc.股票出现异动，股价快速拉升5.51%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426213246861e989e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240426213246861e989e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429118711","title":"Annovis Bio, Inc.盘中异动 股价大涨5.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429118711","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429118711?lang=zh_cn&edition=full","pubTime":"2024-04-23 22:05","pubTimestamp":1713881142,"startTime":"0","endTime":"0","summary":"北京时间2024年04月23日22时05分，Annovis Bio, Inc.股票出现异动，股价急速拉升5.92%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为1.39%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232205437a54efa1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404232205437a54efa1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429924696","title":"Annovis Bio, Inc.盘中异动 大幅拉升5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429924696","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429924696?lang=zh_cn&edition=full","pubTime":"2024-04-22 21:48","pubTimestamp":1713793723,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日21时48分，Annovis Bio, Inc.股票出现异动，股价急速上涨5.77%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042221484487e8281b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042221484487e8281b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428906075","title":"Annovis Bio, Inc.盘中异动 股价大涨5.19%报9.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428906075","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428906075?lang=zh_cn&edition=full","pubTime":"2024-04-18 22:16","pubTimestamp":1713449760,"startTime":"0","endTime":"0","summary":"北京时间2024年04月18日22时16分，Annovis Bio, Inc.股票出现波动，股价大幅上涨5.19%。截至发稿，该股报9.46美元/股，成交量2.7642万股，换手率0.25%，振幅2.95%。Annovis Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418221601792191c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240418221601792191c9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426711810","title":"Annovis Bio, Inc.盘中异动 股价大涨5.41%报12.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426711810","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426711810?lang=zh_cn&edition=full","pubTime":"2024-04-09 22:18","pubTimestamp":1712672315,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日22时18分，Annovis Bio, Inc.股票出现异动，股价快速上涨5.41%。截至发稿，该股报12.08美元/股，成交量2.965万股，换手率0.27%，振幅4.62%。Annovis Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.20%。Annovis Bio, Inc.公司简介：Annovis Bio Inc是一家临床阶段的制药公司，专注于开发和商业化治疗帕金森氏症和阿尔茨海默氏病和其他神经退行性疾病的药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409221835861e43e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409221835861e43e4&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424712457","title":"安诺维斯生物公司公布截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2424712457","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2424712457?lang=zh_cn&edition=full","pubTime":"2024-04-01 21:31","pubTimestamp":1711978279,"startTime":"0","endTime":"0","summary":"   * Annovis Bio Inc   报告了截至12月底的季度调整后每股亏损2.24美元，低于去年同期的每股收益-38美分。五位分析师对该季度的平均预期是每股亏损 1.30 美元。华尔街预期为每股亏损 1.63 美元至 1.06 美元。* Annovis Bio Inc 公布的季度每股收益为亏损 2.24 美元。* 该公司当季亏损 2221 万美元。* 本季度到目前为止，Annovis Bio Inc 的股价保持稳定，今年到目前为止亏损了 36.4%。* 生物技术和医学研究同行的平均一致建议也是 \"买入\"。华尔街对 Annovis Bio Inc 的 12 个月目标价中位数为 30.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2423466988","title":"Annovis Bio Inc   预计每股亏损1.30美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2423466988","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2423466988?lang=zh_cn&edition=full","pubTime":"2024-03-29 20:33","pubTimestamp":1711715628,"startTime":"0","endTime":"0","summary":"   * Annovis Bio Inc    预计在4月1日发布业绩报告时，季度收入将保持不变(预计)，截至2023年12月31日。*    * LSEG 的分析师平均预计 Annovis Bio Inc 每股亏损 1.30 美元。* 目前分析师对该公司股票的平均评级为 \"买入\"，建议的细分为 4 个 \"强烈买入 \"或 \"买入\"，1 个 \"持有\"，没有 \"卖出 \"或 \"强烈卖出\"。* 华尔街对 Annovis Bio Inc 的 12 个月目标价中位数为 30.00 美元，高于其最新收盘价 11.90 美元。3月29日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.annovisbio.com","stockEarnings":[{"period":"1week","weight":-0.5311},{"period":"1month","weight":-0.5319},{"period":"3month","weight":-0.4959},{"period":"6month","weight":-0.0958},{"period":"1year","weight":-0.6249},{"period":"ytd","weight":-0.7021}],"compareEarnings":[{"period":"1week","weight":-0.0073},{"period":"1month","weight":-0.0403},{"period":"3month","weight":0.0396},{"period":"6month","weight":0.1653},{"period":"1year","weight":0.2081},{"period":"ytd","weight":0.0561}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Annovis Bio, Inc.于2008年4月29日根据特拉华州法律注册成立。Annovis是一家临床阶段制药公司，专注于开发和商业化用于治疗帕金森氏症（“PD”）和阿尔茨海默氏症（“AD”）疾病以及其他神经退行性疾病的创新药物。该公司的先导化合物ANVS-401是一种神经化学神经缺陷疗法，可抑制神经变性并抑制神经毒性蛋白质转化为成人和正常化的轴突囊泡转运。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.001878},{"month":2,"riseRate":0.4,"avgChangeRate":0.208855},{"month":3,"riseRate":0.4,"avgChangeRate":-0.008916},{"month":4,"riseRate":0.2,"avgChangeRate":-0.160489},{"month":5,"riseRate":0.5,"avgChangeRate":0.265456},{"month":6,"riseRate":0.75,"avgChangeRate":0.300862},{"month":7,"riseRate":0.5,"avgChangeRate":-0.071309},{"month":8,"riseRate":0.5,"avgChangeRate":-0.04425},{"month":9,"riseRate":0.5,"avgChangeRate":-0.049932},{"month":10,"riseRate":0,"avgChangeRate":-0.151029},{"month":11,"riseRate":0.75,"avgChangeRate":0.114437},{"month":12,"riseRate":0.5,"avgChangeRate":0.329002}],"exchange":"NYSE","name":"Annovis Bio, Inc.","nameEN":"Annovis Bio, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Annovis Bio, Inc.(ANVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Annovis Bio, Inc.,ANVS,Annovis Bio, Inc.股票,Annovis Bio, Inc.股票老虎,Annovis Bio, Inc.股票老虎国际,Annovis Bio, Inc.行情,Annovis Bio, Inc.股票行情,Annovis Bio, Inc.股价,Annovis Bio, Inc.股市,Annovis Bio, Inc.股票价格,Annovis Bio, Inc.股票交易,Annovis Bio, Inc.股票购买,Annovis Bio, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Annovis Bio, Inc.(ANVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Annovis Bio, Inc.(ANVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}